4 free views remaining today
familial glucocorticoid deficiency
Description
Familial glucocorticoid deficiency (FGD) is a rare genetic disorder characterized by primary adrenal insufficiency, leading to a deficiency in cortisol production. This condition is caused by mutations in genes responsible for the production or function of enzymes involved in cortisol biosynthesis.
Key Features:
- Primary adrenal insufficiency
- Deficiency in cortisol production
- Neonatal hyperpigmentation (skin darkening)
- Hypoglycemia (low blood sugar)
- Failure to thrive (poor weight gain and growth)
- Feeding problems, including chronic spitting or vomiting and poor appetite
Symptoms:
- In early life, patients may experience feeding difficulties, failure to thrive, hypoglycemic seizures, and lethargy.
- Older children and adults may exhibit symptoms such as fatigue, weakness, weight loss, and skin hyperpigmentation.
Causes:
- FGD is caused by mutations in genes responsible for cortisol biosynthesis, leading to a deficiency in cortisol production.
- The condition is inherited in an autosomal recessive pattern, meaning that both parents must be carriers of the mutated gene for their child to inherit the condition.
References:
- [1] Familial glucocorticoid deficiency is a group of primary adrenal insufficiencies characterized clinically by neonatal hyperpigmentation, hypoglycemia, and failure to thrive. (Source: #3)
- [2] The presenting symptoms in the neonatal period include feeding difficulty, failure to thrive, regurgitation, and hypoglycemia manifesting as seizures, lethargy, and poor appetite. (Source: #2)
- [3] FGD is a condition characterized by primary adrenal insufficiencies, neonatal hyperpigmentation, hypoglycemia, failure to thrive, and feeding problems. (Source: #9)
Additional Characteristics
- Weight loss
- Weakness
- Fatigue
- Hypoglycemia (low blood sugar)
- Failure to thrive (poor weight gain and growth)
- Skin hyperpigmentation
- Primary adrenal insufficiency
- Deficiency in cortisol production
- Neonatal hyperpigmentation (skin darkening)
- Feeding problems, including chronic spitting or vomiting and poor appetite
Signs and Symptoms
Familial glucocorticoid deficiency is a rare genetic disorder that affects the adrenal glands' ability to produce sufficient amounts of glucocorticoids, essential hormones for stress response, metabolism, and immune response. The signs and symptoms of this condition can vary depending on the underlying cause and severity.
Common Signs and Symptoms:
- Low Blood Glucose (Hypoglycemia): Most affected children first develop low blood glucose, which can manifest as seizures, lethargy, or feeding difficulty in infants [5].
- Failure to Thrive: Children with familial glucocorticoid deficiency may fail to grow and gain weight at the expected rate due to inadequate hormone production.
- Hyperpigmentation: Deep hyperpigmentation of the skin is a common initial presenting sign and is almost always present at diagnosis [7].
- Recurrent Infections: Affected individuals are more prone to recurrent infections, which can be severe and life-threatening if left untreated.
- Fatigue, Weakness, Weight Loss, Decreased Appetite: These symptoms may occur in some cases, although they are not as common as the above-mentioned signs [4].
- Hypotension (Low Blood Pressure): Some individuals with familial glucocorticoid deficiency may experience low blood pressure, which can lead to dizziness or fainting upon standing.
- Muscle Aches and Pains: Muscle aches and pains are also possible symptoms of this condition.
Other Features:
- Skin Coloring Darker than Family Members: Some individuals with familial glucocorticoid deficiency may have skin coloring darker than that of other family members [6].
- Neonatal Hyperpigmentation: This is a characteristic feature of the condition, particularly in infants [10].
It's essential to note that these symptoms can vary in severity and presentation depending on the individual case. If you suspect familial glucocorticoid deficiency or any other rare genetic disorder, it's crucial to consult with a qualified healthcare professional for proper diagnosis and treatment.
References:
[1] - Not provided (context 1) [2] - Not provided (context 2) [3] - Not provided (context 3) [4] - Context 4 [5] - Context 5 [6] - Context 6 [7] - Context 7 [10] - Context 10
Additional Symptoms
- Recurrent Infections
- Low Blood Glucose (Hypoglycemia)
- Fatigue, Weakness, Weight Loss, Decreased Appetite
- Hypotension (Low Blood Pressure)
- Muscle Aches and Pains
- Skin Coloring Darker than Family Members
- hyperpigmentation
- failure to thrive
Diagnostic Tests
Familial glucocorticoid deficiency (FGD) can be diagnosed through various laboratory tests that measure the levels of certain hormones and their stimulating factors in the blood.
- Cortrosyn stimulation test: This is a key diagnostic test for FGD, which involves administering Cortrosyn (a synthetic form of ACTH) to the patient and measuring the resulting cortisol levels. A normal response would indicate adequate glucocorticoid production, while a blunted or absent response suggests FGD [2][4].
- Biochemical tests: These include measurements of cortisol, ACTH, aldosterone, and renin levels in the blood. In FGD patients, these tests typically show low cortisol levels, high ACTH levels, normal aldosterone levels, and normal renin levels [4].
- Genetic testing: Genetic mutations in the MC2R gene can be identified through genetic testing, which can confirm a diagnosis of FGD in individuals with a family history of the condition or those who have already undergone biochemical testing [3][7].
It's worth noting that the Cortrosyn stimulation test is particularly useful for diagnosing FGD during acute illness, when cortisol levels may be low due to stress [5]. Additionally, genetic testing can provide a definitive diagnosis and help identify carriers of the MC2R mutation in family members [6].
References: [1] Not applicable (since there's no relevant information on this topic) [2] Context #4 [3] Context #3 [4] Context #4 [5] Context #5 [6] Context #7 [7] Context #7
Additional Diagnostic Tests
- Biochemical tests
- Genetic testing
- Cortrosyn stimulation test
Treatment
Treatment Overview
Familial glucocorticoid deficiency (FGD) is a rare genetic disorder characterized by the adrenal glands' inability to produce sufficient glucocorticoids, leading to various symptoms such as hypoglycemia, weakness, and hyperpigmentation. The primary treatment for FGD involves replacing the deficient glucocorticoids with synthetic hormones.
Replacement Therapy
The mainstay of treatment in FGD is replacement therapy with oral hydrocortisone [1]. A dosage of 10-12 mg/m2/day (usually divided into three doses) normalizes cortisol levels and helps alleviate symptoms. This therapy aims to mimic the body's natural production of glucocorticoids, thereby preventing complications associated with adrenal insufficiency.
Glucocorticoid Replacement Options
Other glucocorticoid replacement options include prednisone [6] and methylprednisolone [6], which can be used in place of hydrocortisone. These hormones are given on a schedule to act as a substitute for the deficient cortisol, helping to maintain normal physiological functions.
Stress Dosing
In children, hydrocortisone (∼8 mg/m2/d) is recommended [7]. Patients should be educated about stress dosing and equipped with a steroid card and glucocorticoid replacement instructions. This ensures that they can manage their condition effectively during periods of increased physiological demand.
Adrenal Insufficiency Management
For patients with suspected but unproved adrenal insufficiency, dexamethasone is best used to correct the glucocorticoid deficiency [8]. Treatment of adrenal insufficiency requires daily treatment with glucocorticoid and mineralocorticoid pills [9].
Glucocorticoid Therapy Dose
The dose of glucocorticoid therapy poses a risk for adrenal insufficiency – any dose greater than the daily hydrocortisone equivalent of 15-25 mg (4-6 mg prednisone or 2-3 mg methylprednisolone) [10].
References:
[1] Treatment consists of a replacement therapy with oral hydrocortisone. A dosage of 10-12 mg/m2/day (usually divided into three doses) normalizes cortisol and ...
[2] by RK Gupta · 2011 · Cited by 6 — The mainstay of treatment in FGD is the replacement of glucocorticoids.
[3] by A Mazur · 2007 · Cited by 3 — Treatment of FGD includes substitution of glucocorticoids with dose adjustment depending on the clinical state.
[4] Feb 1, 2015 — Familial glucocorticoid deficiency is a condition that occurs when the adrenal glands do not produce certain hormones called glucocorticoids.
[6] Feb 16, 2019 — Clinically judge the adequacy of glucocorticoid treatment by documenting reduced hyperpigmentation, absence of hypoglycemia and weakness, and ...
[7] by SR Bornstein · 2016 · Cited by 1704 — In children, hydrocortisone (∼8 mg/m2/d) is recommended.
[8] Dec 14, 2021 — For a patient with suspected but unproved adrenal insufficiency, dexamethasone is best used to correct the glucocorticoid deficiency.
[9] May 17, 2023 — Primary adrenal insufficiency — Treatment of adrenal insufficiency requires daily treatment with glucocorticoid and mineralocorticoid pills,
[10] by F Beuschlein · 2024 · Cited by 14 — Dose of glucocorticoid therapy to pose risk for adrenal insufficiency – any dose greater than daily hydrocortisone equivalent of 15-25 mg (4-6 mg prednisone or ...
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses of Familial Glucocorticoid Deficiency (FGD)
Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by isolated glucocorticoid deficiency in the absence of mineralocorticoid deficiency. The differential diagnosis of FGD includes several conditions that can present with similar clinical features.
- Addison's disease: This condition, also known as primary adrenal insufficiency, is caused by autoimmune destruction of the adrenal glands, leading to a deficiency of both glucocorticoids and mineralocorticoids [1].
- 3-Beta-Hydroxysteroid Dehydrogenase Deficiency: This rare genetic disorder affects the production of all steroid hormones, including glucocorticoids and mineralocorticoids [5][9].
- Adrenal Hypoplasia: A rare congenital condition characterized by underdevelopment of the adrenal glands, leading to impaired hormone production, including glucocorticoids [4][9].
- Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): While not directly related to adrenal function, this condition can present with symptoms similar to FGD, such as fatigue and hypoglycemia [5].
Key Features of Differential Diagnoses
- Addison's disease is often associated with mineralocorticoid deficiency, whereas FGD is characterized by isolated glucocorticoid deficiency.
- 3-Beta-Hydroxysteroid Dehydrogenase Deficiency affects the production of all steroid hormones, making it a more severe condition than FGD.
- Adrenal Hypoplasia is a congenital condition that can present with impaired hormone production, including glucocorticoids.
References
[1] The main differential diagnosis of FGD is Addison's disease (usually of autoimmune origin), in which case a mineralocorticoid deficiency is present. [1] [2] 3-Beta-Hydroxysteroid Dehydrogenase Deficiency · Adrenal Hypoplasia · Birth Trauma · Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) [5][9] [3] Familial glucocorticoid deficiency is a rare disease with nonspecific clinical presentations that can lead to late diagnosis with high rates of misdiagnosis. [3]
Note: The numbers in square brackets refer to the search results provided in the context, which were used to generate this answer.
Additional Differential Diagnoses
- 3-Beta-Hydroxysteroid Dehydrogenase Deficiency
- Adrenal Hypoplasia
- Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
- Birth Trauma
- Addison's disease
Additional Information
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_9553
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3488
- owl#annotatedSource
- t357169
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080620
- core#notation
- DOID:0080620
- oboInOwl#hasDbXref
- MIM:PS202200
- IAO_0000115
- An adrenal cortex disease that is characterized by insufficient production of glucocorticoids.
- rdf-schema#label
- familial glucocorticoid deficiency
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.